Skip to main content
Top
Gepubliceerd in:

01-09-2007 | case report

Prosthetic heart valve thrombosis, anticoagulation and pregnancy: a case report and review of literature

Auteurs: J. T. van Kuilenburg, F. W. A. Verheugt, A. P. J. van Dijk

Gepubliceerd in: Netherlands Heart Journal | Uitgave 9/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

In pregnant patients with a prosthetic heart valve (PHV), anticoagulation with warfarin is associated with embryopathy, foetal loss early in pregnancy and maternal bleeding complications in the delivery period. The optimal anticoagulation strategy in the pre-pregnancy period and during pregnancy itself is controversial and a matter of debate. We describe a patient with PHV in the pre-pregnancy period and in a subsequent pregnancy. The optimal anticoagulation treatment strategy in women in their reproductive years with mechanical valve thrombosis is discussed. (Neth Heart J 2007;15: 306-9).
Literatuur
go back to reference Piper C, Hering D, Horstkotte D. Prosthetic valve thrombosis: predisposition and diagnosis. Eur Heart J 2001;22(Suppl):Q16-Q21. Piper C, Hering D, Horstkotte D. Prosthetic valve thrombosis: predisposition and diagnosis. Eur Heart J 2001;22(Suppl):Q16-Q21.
go back to reference Horstkotte D, Hering D, Faber L, Piper C. Cardiac morphology and physiology predisposing to thrombus formation. Eur Heart J 2001;3(Suppl):Q8-Q11. Horstkotte D, Hering D, Faber L, Piper C. Cardiac morphology and physiology predisposing to thrombus formation. Eur Heart J 2001;3(Suppl):Q8-Q11.
go back to reference Horstkotte D, Haerten K, Herzer JA. Five year results after randomised mitral valve replacements with Bjork-Shiley, Lillehei-Kaster and Starr-Edwards prostheses. J Thorac Cardiovasc Surg 1983;31:206-14. Horstkotte D, Haerten K, Herzer JA. Five year results after randomised mitral valve replacements with Bjork-Shiley, Lillehei-Kaster and Starr-Edwards prostheses. J Thorac Cardiovasc Surg 1983;31:206-14.
go back to reference Anderson JM, Schoen EJ. Interaction of blood with artificial surfaces. In: Thrombosis, Embolism and Bleeding. Butchart E, Bodnar E, eds. London, ICR Publishers 1992. Anderson JM, Schoen EJ. Interaction of blood with artificial surfaces. In: Thrombosis, Embolism and Bleeding. Butchart E, Bodnar E, eds. London, ICR Publishers 1992.
go back to reference Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:S627-44. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126:S627-44.
go back to reference Iturbe-Alessio I, Fonseca MC, Mutchinik O, et al. Risks of anticoagulant therapy in pregnant women with artificial heart valve. N Engl J Med 1986; 315:1390-3. Iturbe-Alessio I, Fonseca MC, Mutchinik O, et al. Risks of anticoagulant therapy in pregnant women with artificial heart valve. N Engl J Med 1986; 315:1390-3.
go back to reference Ginsberg JS, Greer IA, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S-31S. Ginsberg JS, Greer IA, Hirsh J. Use of antithrombotic agents during pregnancy. Chest 2001;119:122S-31S.
go back to reference Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-40. Hall JG, Pauli RM, Wilson KM. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 1980;68:122-40.
go back to reference Wang V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulation during pregnancy. Am J Med Gen 1993;45:17-21. Wang V, Cheng CH, Chan KC. Fetal and neonatal outcome of exposure to anticoagulation during pregnancy. Am J Med Gen 1993;45:17-21.
go back to reference Vitale N, De Feo M, De Santo LS, et al. Dose dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41. Vitale N, De Feo M, De Santo LS, et al. Dose dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999;33:1637-41.
go back to reference Oakley CM. Anticoagulants in pregnancy. Br Heart J 1995;74: 107-11. Oakley CM. Anticoagulants in pregnancy. Br Heart J 1995;74: 107-11.
go back to reference Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of literature. Arch Intern Med 2000;160:191-6. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of literature. Arch Intern Med 2000;160:191-6.
go back to reference Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valve disease. J Am Coll Cardiol 2005;46:403-10. Elkayam U, Bitar F. Valvular heart disease and pregnancy: part II: prosthetic valve disease. J Am Coll Cardiol 2005;46:403-10.
go back to reference Butchart E, Gohlke-Bärwolf C, Antunes MJ, et al. Recommendations for the management of patients after heart valve surgery, Eur Heart J 2005;26:2463-71. Butchart E, Gohlke-Bärwolf C, Antunes MJ, et al. Recommendations for the management of patients after heart valve surgery, Eur Heart J 2005;26:2463-71.
go back to reference Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, et al. ACC/AHA Task force report: ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-588. Bonow RO, Carabello B, de Leon AC Jr, Edmunds LH Jr, et al. ACC/AHA Task force report: ACC/AHA Guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 1998;32:1486-588.
go back to reference Lengyel M. Management of prosthetic valve thrombosis. J Heart Valve Dis 2004;13:329-44. Lengyel M. Management of prosthetic valve thrombosis. J Heart Valve Dis 2004;13:329-44.
go back to reference Lengyel M. Thrombolysis should be regarded as first line therapy for prosthetic valve thrombosis in the absence of contraindications J Am Coll Cardiol 2005;18:45. Lengyel M. Thrombolysis should be regarded as first line therapy for prosthetic valve thrombosis in the absence of contraindications J Am Coll Cardiol 2005;18:45.
go back to reference Lopez HP, Caceres Loriga FM, Hernandez KM, et al. Thrombolytic therapy with recombinant streptokinase for prosthetic valve thrombosis. J Card Surg 2002;17:387-93. Lopez HP, Caceres Loriga FM, Hernandez KM, et al. Thrombolytic therapy with recombinant streptokinase for prosthetic valve thrombosis. J Card Surg 2002;17:387-93.
go back to reference Lengyel M. Guidelines for management of left-sided prosthetic valve prosthetic valve thrombosis: a role for thrombolytic therapy: Consensus conference on prosthetic valve thrombosis. J Am Coll Cardiol 2004;30:1521-6. Lengyel M. Guidelines for management of left-sided prosthetic valve prosthetic valve thrombosis: a role for thrombolytic therapy: Consensus conference on prosthetic valve thrombosis. J Am Coll Cardiol 2004;30:1521-6.
go back to reference Hurrell DG, Schaff HV, Tajik A, et al. Thrombolytic therapy for obstruction of mechanical prosthetic valves. Mayo Clin Proc 1996;71:605-13. Hurrell DG, Schaff HV, Tajik A, et al. Thrombolytic therapy for obstruction of mechanical prosthetic valves. Mayo Clin Proc 1996;71:605-13.
go back to reference Anbarasan C, Kumar VS, Ladchumanadhas K, et al. Successful thrombolysis of prosthetic mitral valve thrombosis in early pregnancy. J Heart Valve Dis 2001;10:393-5. Anbarasan C, Kumar VS, Ladchumanadhas K, et al. Successful thrombolysis of prosthetic mitral valve thrombosis in early pregnancy. J Heart Valve Dis 2001;10:393-5.
go back to reference Lengyel M, Horstkotte D, Voller H, et al. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005;14:467-75. Lengyel M, Horstkotte D, Voller H, et al. Recommendations for the management of prosthetic valve thrombosis. J Heart Valve Dis 2005;14:467-75.
go back to reference Rahman AM, Birnbaum Y, Mandava P, et al. Abciximab treatment for obstruction prosthetic aortic and mitral valve thrombosis in the presence of large thrombi in the presence of cardiogenic, and acute evolving stroke. Echocardiography 2004;21:55. Rahman AM, Birnbaum Y, Mandava P, et al. Abciximab treatment for obstruction prosthetic aortic and mitral valve thrombosis in the presence of large thrombi in the presence of cardiogenic, and acute evolving stroke. Echocardiography 2004;21:55.
Metagegevens
Titel
Prosthetic heart valve thrombosis, anticoagulation and pregnancy: a case report and review of literature
Auteurs
J. T. van Kuilenburg
F. W. A. Verheugt
A. P. J. van Dijk
Publicatiedatum
01-09-2007
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Netherlands Heart Journal / Uitgave 9/2007
Print ISSN: 1568-5888
Elektronisch ISSN: 1876-6250
DOI
https://doi.org/10.1007/BF03086005